Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China National Medicines Corporation Ltd. is a leading pharmaceutical distribution and service provider in China, operating as a core subsidiary of the state-owned Sinopharm Group. The company holds a dominant market position in the national distribution of narcotics and psychotropic drugs, maintaining a specialized supply chain that serves the entire country. Beyond its wholesale operations, it provides comprehensive logistics, marketing, and retail services for a wide array of pharmaceutical products and medical devices. Headquartered in Beijing and listed on the Shanghai Stock Exchange, the company plays a critical role in China's national drug reserve and emergency medical supply systems. It serves as a vital bridge between domestic and international pharmaceutical manufacturers and the Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China National Medicines.